4.7 Article

ARGONAUT II Study of the In Vitro Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniae

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 5, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00012-20

Keywords

Klebsiella; antibiotic resistance; carbapenemase; plazomicin

Funding

  1. National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [UM1AI104681]
  2. NIH [R01AI100560, R01AI063517, R01AI072219, R01AI090155]
  3. National Institute of Allergy and Infectious Diseases [U19AI110819]
  4. Cleveland Department of Veterans Affairs from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [1I01BX001974]
  5. Geriatric Research Education and Clinical Center [VISN 10]
  6. Achaogen

Ask authors/readers for more resources

Plazomicin was tested against 697 recently acquired carbapenemresistant Klebsiella pneumoniae isolates from the Great Lakes region of the United States. Plazomicin MIC50 and MIC90 values were 0.25 and 1 mg/liter, respectively; 680 isolates (97.6%) were susceptible (MICs of <= 2 mg/liter), 9 (1.3%) intermediate (MICs of 4 mg/liter), and 8 (1.1%) resistant (MICs of > 32 mg/liter). Resistance was associated with rmtF-, rmtB-, or armA-encoded 16S rRNA methyltransferases in all except 1 isolate.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available